Correlation Between Microbix Biosystems and Oncolytics Biotech

Can any of the company-specific risk be diversified away by investing in both Microbix Biosystems and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microbix Biosystems and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microbix Biosystems and Oncolytics Biotech, you can compare the effects of market volatilities on Microbix Biosystems and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microbix Biosystems with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microbix Biosystems and Oncolytics Biotech.

Diversification Opportunities for Microbix Biosystems and Oncolytics Biotech

-0.58

Correlation Coefficient

Microbix Biosystems  Oncolytics Biotech

Excellent diversification

The 3 months correlation between Microbix and Oncolytics is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Microbix Biosystems and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Microbix Biosystems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microbix Biosystems are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Microbix Biosystems i.e., Microbix Biosystems and Oncolytics Biotech go up and down completely randomly.

Pair Corralation between Microbix Biosystems and Oncolytics Biotech

Assuming the 90 days trading horizon Microbix Biosystems is expected to under-perform the Oncolytics Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Microbix Biosystems is 3.05 times less risky than Oncolytics Biotech. The stock trades about -0.08 of its potential returns per unit of risk. The Oncolytics Biotech is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  81.00  in Oncolytics Biotech on April 24, 2025 and sell it today you would earn a total of  86.00  from holding Oncolytics Biotech or generate 106.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Microbix Biosystems  vs.  Oncolytics Biotech

Microbix Biosystems

Risk-Adjusted Performance

Very Weak

Over the last 90 days Microbix Biosystems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in August 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Oncolytics Biotech

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Oncolytics Biotech are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Oncolytics Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Microbix Biosystems and Oncolytics Biotech

The main advantage of trading using opposite Microbix Biosystems and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microbix Biosystems position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.

The idea behind Microbix Biosystems and Oncolytics Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.